Free Trial

Warby Parker Inc. (NYSE:WRBY) Shares Sold by Baillie Gifford & Co.

Warby Parker logo with Medical background

Baillie Gifford & Co. decreased its position in Warby Parker Inc. (NYSE:WRBY - Free Report) by 63.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,235,169 shares of the company's stock after selling 3,840,821 shares during the quarter. Baillie Gifford & Co. owned approximately 2.25% of Warby Parker worth $35,897,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in WRBY. Vaughan Nelson Investment Management L.P. lifted its stake in shares of Warby Parker by 113.3% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 2,477,410 shares of the company's stock worth $39,787,000 after purchasing an additional 1,315,672 shares during the period. TimesSquare Capital Management LLC raised its stake in shares of Warby Parker by 149.4% in the first quarter. TimesSquare Capital Management LLC now owns 1,687,750 shares of the company's stock worth $22,970,000 after buying an additional 1,011,030 shares during the period. Jennison Associates LLC purchased a new stake in Warby Parker during the fourth quarter valued at approximately $12,034,000. Vanguard Group Inc. increased its position in shares of Warby Parker by 7.7% during the 4th quarter. Vanguard Group Inc. now owns 8,457,986 shares of the company's stock valued at $119,258,000 after purchasing an additional 607,352 shares during the last quarter. Finally, Zweig DiMenna Associates LLC bought a new stake in shares of Warby Parker in the 2nd quarter worth about $5,183,000. 93.24% of the stock is currently owned by hedge funds and other institutional investors.


Insider Transactions at Warby Parker

In other Warby Parker news, Director Bradley E. Singer purchased 50,000 shares of Warby Parker stock in a transaction dated Tuesday, August 13th. The shares were acquired at an average price of $13.00 per share, with a total value of $650,000.00. Following the completion of the transaction, the director now owns 100,000 shares of the company's stock, valued at $1,300,000. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Warby Parker news, Director Bradley E. Singer acquired 50,000 shares of the company's stock in a transaction dated Tuesday, August 13th. The shares were acquired at an average price of $13.00 per share, for a total transaction of $650,000.00. Following the acquisition, the director now owns 100,000 shares in the company, valued at approximately $1,300,000. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Steven Clive Miller sold 15,709 shares of the stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $17.04, for a total transaction of $267,681.36. Following the completion of the transaction, the chief financial officer now directly owns 166,879 shares in the company, valued at $2,843,618.16. The disclosure for this sale can be found here. Insiders sold a total of 5,848,537 shares of company stock worth $91,938,722 over the last ninety days. Company insiders own 26.55% of the company's stock.

Warby Parker Price Performance

WRBY traded up $1.65 during trading hours on Friday, reaching $15.51. The company's stock had a trading volume of 5,437,694 shares, compared to its average volume of 1,681,793. Warby Parker Inc. has a fifty-two week low of $9.83 and a fifty-two week high of $17.95. The business's 50-day moving average is $15.37 and its 200-day moving average is $14.50. The stock has a market cap of $1.56 billion, a PE ratio of -33.00 and a beta of 1.82.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Telsey Advisory Group reissued an "outperform" rating and set a $19.00 target price on shares of Warby Parker in a research note on Thursday, August 8th. Loop Capital lifted their target price on Warby Parker from $15.00 to $16.00 and gave the company a "hold" rating in a research report on Wednesday, July 10th. Stifel Nicolaus raised their price target on Warby Parker from $14.00 to $15.00 and gave the company a "hold" rating in a research note on Friday, August 9th. UBS Group increased their target price on shares of Warby Parker from $13.00 to $15.00 and gave the stock a "neutral" rating in a report on Friday, May 10th. Finally, JMP Securities raised shares of Warby Parker from a "market perform" rating to an "outperform" rating and set a $20.00 price target for the company in a research report on Friday. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Warby Parker has a consensus rating of "Moderate Buy" and a consensus price target of $17.11.

Get Our Latest Analysis on Warby Parker

Warby Parker Company Profile

(Free Report)

Warby Parker Inc provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps.

See Also

Institutional Ownership by Quarter for Warby Parker (NYSE:WRBY)

Should you invest $1,000 in Warby Parker right now?

Before you consider Warby Parker, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Warby Parker wasn't on the list.

While Warby Parker currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Beyond Meat Stock: Not Beyond Hope?
Palantir’s Big Move: What Does Joining the S&P 500 Mean for Investors?
RH Stock: A Hidden Opportunity for Short Sellers?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines